• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唾液中天疱疮桥粒芯糖蛋白1和桥粒芯糖蛋白3自身抗体以及类天疱疮BP180自身抗体的检测及其与血清值的比较。

Detection of pemphigus desmoglein 1 and desmoglein 3 autoantibodies and pemphigoid BP180 autoantibodies in saliva and comparison with serum values.

作者信息

Andreadis Dimitrios, Lorenzini Guido, Drakoulakos Drakoulis, Belazi Maria, Mihailidou Euaggelia, Velkos Georgios, Mourellou-Tsatsou Olga, Antoniades Demetrios

机构信息

Department of Oral Medicine and Maxillofacial Pathology, School of Dentistry, Aristotle University of Thessaloniki, Greece.

出版信息

Eur J Oral Sci. 2006 Oct;114(5):374-80. doi: 10.1111/j.1600-0722.2006.00394.x.

DOI:10.1111/j.1600-0722.2006.00394.x
PMID:17026501
Abstract

Although there is much literature on the detection of pemphigus and pemphigoid autoantibodies by enzyme-linked immunosorbent assay (ELISA) in serum, nothing is known about their presence in saliva. The aim of this study was to evaluate the salivary levels of these autoantibodies in pemphigus and pemphigoid patients. Autoantibodies against desmoglein3, desmoglein1, and BP180 were assayed, by ELISA, in serum and saliva samples of patients and healthy controls. The titres of autoantibodies against Dsg1/3 found in both serum and saliva of pemphigus patients showed a statistically significant correlation, suggesting that saliva may be a useful biological material for diagnostic purposes, in monitoring disease activity, as well as for the early detection of relapses. By contrast, the titres of autoantibodies against BP180 in the serum and saliva of bullous pemphigoid patients were not statistically related, and further study of the usefulness of the BP180 ELISA for saliva in this disease is needed. In addition, based on our results, the BP180 ELISA with a recombinant NC16a epitope failed to detect the autoantibodies against BP180 in the serum and saliva of mucous membrane pemphigoid patients.

摘要

虽然有许多文献报道了通过酶联免疫吸附测定(ELISA)检测血清中的天疱疮和类天疱疮自身抗体,但对于它们在唾液中的存在情况却一无所知。本研究的目的是评估天疱疮和类天疱疮患者唾液中这些自身抗体的水平。通过ELISA检测患者和健康对照者血清及唾液样本中针对桥粒芯糖蛋白3、桥粒芯糖蛋白1和BP180的自身抗体。天疱疮患者血清和唾液中针对桥粒芯糖蛋白1/3的自身抗体滴度显示出统计学上的显著相关性,这表明唾液可能是用于诊断目的、监测疾病活动以及早期检测复发的有用生物材料。相比之下,大疱性类天疱疮患者血清和唾液中针对BP180的自身抗体滴度无统计学相关性,因此需要进一步研究BP180 ELISA在该疾病唾液检测中的实用性。此外,根据我们的结果,使用重组NC16a表位的BP180 ELISA未能检测出黏膜类天疱疮患者血清和唾液中针对BP180的自身抗体。

相似文献

1
Detection of pemphigus desmoglein 1 and desmoglein 3 autoantibodies and pemphigoid BP180 autoantibodies in saliva and comparison with serum values.唾液中天疱疮桥粒芯糖蛋白1和桥粒芯糖蛋白3自身抗体以及类天疱疮BP180自身抗体的检测及其与血清值的比较。
Eur J Oral Sci. 2006 Oct;114(5):374-80. doi: 10.1111/j.1600-0722.2006.00394.x.
2
Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.自身免疫性水疱病的酶联免疫吸附测定:卡利亚里皮肤科的初步经验
G Ital Dermatol Venereol. 2008 Feb;143(1):1-8.
3
Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.BP180-NC16a酶联免疫吸附测定法在大疱性类天疱疮初始诊断中的评估
Br J Dermatol. 2004 Jul;151(1):126-31. doi: 10.1111/j.1365-2133.2004.06082.x.
4
Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.使用桥粒芯糖蛋白酶联免疫吸附测定法评估血浆置换治疗天疱疮患者的疗效。
Br J Dermatol. 2008 Apr;158(4):685-90. doi: 10.1111/j.1365-2133.2007.08416.x. Epub 2008 Jan 30.
5
Desmoglein1 and BP 180 ELISA indexes correlating with disease activity in a patient with coexisting pemphigus foliaceus and bullous pemphigoid.在一位天疱疮落叶型和大疱性类天疱疮共存患者中,桥粒芯糖蛋白1和BP180 ELISA指标与疾病活动相关。
Clin Exp Dermatol. 2009 Dec;34(8):e995-6. doi: 10.1111/j.1365-2230.2009.03656.x.
6
Validation of chemiluminescent enzyme immunoassay in detection of autoantibodies in pemphigus and pemphigoid.化学发光酶免疫测定法在检测天疱疮和类天疱疮自身抗体中的验证
J Dermatol Sci. 2017 Mar;85(3):208-215. doi: 10.1016/j.jdermsci.2016.12.007. Epub 2016 Dec 6.
7
Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.伊朗寻常型天疱疮患者中桥粒芯糖蛋白1和3酶联免疫吸附测定:与表型、严重程度及疾病活动度的相关性
J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1319-24. doi: 10.1111/j.1468-3083.2007.02254.x.
8
Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients.新型 ELISA 系统检测抗桥粒芯糖蛋白 1 和 3 抗体:与个体天疱疮患者血清自身抗体水平相关的疾病活动度。
Exp Dermatol. 2010 May;19(5):458-63. doi: 10.1111/j.1600-0625.2010.01069.x. Epub 2010 Feb 16.
9
[Anti-desmoglein 1 and 3 antibody, anti-BP180(NC16a) antibody, anti-BP230 antibody].[抗桥粒芯糖蛋白1和3抗体、抗BP180(NC16a)抗体、抗BP230抗体]
Nihon Rinsho. 2010 Jun;68 Suppl 6:614-7.
10
Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China.BP180NC16a酶联免疫吸附测定(ELISA)在中国大疱性类天疱疮诊断中的作用。
Int J Dermatol. 2008 Jan;47(1):24-8. doi: 10.1111/j.1365-4632.2007.03531.x.

引用本文的文献

1
Saliva as a Diagnostic Tool for Systemic Diseases-A Narrative Review.唾液作为全身性疾病的诊断工具——一篇叙述性综述。
Medicina (Kaunas). 2025 Jan 30;61(2):243. doi: 10.3390/medicina61020243.
2
Evaluation of the Role of Oral Mucosal Direct Immunofluorescence and Salivary Desmoglein 1 and 3 Enzyme-Linked Immunosorbent Assay in Patients With Oral Mucosal Pemphigus.口腔黏膜直接免疫荧光及唾液桥粒芯糖蛋白1和3酶联免疫吸附测定在口腔黏膜天疱疮患者中的作用评估
Indian Dermatol Online J. 2022 Sep 5;13(5):617-619. doi: 10.4103/idoj.idoj_44_22. eCollection 2022 Sep-Oct.
3
Saliva Proteomics as Fluid Signature of Inflammatory and Immune-Mediated Skin Diseases.
唾液蛋白质组学:炎症性和免疫介导性皮肤病的体液标志物
Int J Mol Sci. 2021 Jun 29;22(13):7018. doi: 10.3390/ijms22137018.
4
Saliva and Oral Diseases.唾液与口腔疾病
J Clin Med. 2020 Feb 8;9(2):466. doi: 10.3390/jcm9020466.
5
Saliva as a Future Field in Psoriasis Research.唾液作为银屑病研究的未来领域。
Biomed Res Int. 2018 May 20;2018:7290913. doi: 10.1155/2018/7290913. eCollection 2018.